InsidersTradesSigma
Track the ARTRYA LIMITED share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €694.3m. The latest transaction was disclosed on 10 September 2026 (Change in Substantial Holding). Among the most active insiders: Bernie Ridgeway. The full history is free.
Analysts rate ARTRYA LIMITED Strong Buy (bullish), based on 3 analysts. Average price target: A$6.24.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
ARTRYA LIMITED 是一家在 XASX 上市的公司，专注于开发心脏健康技术解决方案。它旨在通过数字创新改善临床结果。